Nowadays, peptides are one such therapy among gymgoers
Weight regain is one of the most documented consequences of stopping GLP-1 therapy
[1] point out that elevated appetite with WL is often detected in premeal or postabsorptive sensations related to appetites, such as the desire to eat or craving
No statistically significant differences were observed for wound infection, cellulitis, wound disruption, hemorrhage, hypertrophic scarring, need for additional Mohs stages, or several rare complications
Yes, tirzepatide and metformin can be taken together safely as they work through different mechanisms without significant drug interactions
For us as clinicians, the 2035 projections map directly onto the chronic disease burden we'll be managingmore diabetes, more cardiovascular disease, more musculoskeletal disease, more Alzheimer's, and higher costs across the board